14. Segment Reporting

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Segment Reporting

Selected financial information for the Company’s operating segments is as follows:

	Year Ended December 31,
	2016			2015
Net revenues - External
Clinical Laboratory Operations	$	3,716,662		$	17,501,189
Supportive Software Solutions		834,158			805,899
Decision Support and Informatics		694,291			85,950
	$	5,245,111		$	18,393,038
Net revenues - Intersegment
Supportive Software Solutions		1,254,338			2,096,768
	$	1,254,338		$	2,096,768
(Loss) income from operations
Clinical Laboratory Operations	$	(15,513,290	)	$	(17,197,888	)
Supportive Software Solutions		(4,559,069	)		(7,810,476	)
Decision Support and Informatics		(3,065,657	)		(13,023,465	)
Corporate		(9,389,519	)		(7,488,351	)
Eliminations		134,647			55,206
	$	(32,392,888	)	$	(45,464,974	)
Depreciation and amortization
Clinical Laboratory Operations	$	2,485,207		$	2,178,423
Supportive Software Solutions		651,872			678,201
Decision Support and Informatics		41,462			8,006
Corporate		3,008			5,424
Eliminations		(134,647	)		(120,204	)
	$	3,046,902		$	2,749,850
Capital expenditures
Clinical Laboratory Operations	$	25,009		$	419,068
Supportive Software Solutions		1,875			102,235
Decision Support and Informatics		9,844			–
Eliminations		–			(65,000	)
	$	36,728		$	456,303

	December 31,			December 31,
	2016			2015
Total assets
Clinical Laboratory Operations	$	4,081,136		$	15,152,583
Supportive Software Solutions		2,602,428			2,896,473
Decision Support and Informatics		379,652			4,307,053
Corporate		2,130,191			14,109,337
Eliminations		(2,711,014	)		(7,095,520	)
	$	6,482,393		$	29,369,926